Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
101.49
+0.20 (0.20%)
Mar 3, 2026, 2:11 PM EST - Market open

Nuvalent Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
107.3462.5936.2522.3810.26
Research & Development
306.97217.77113.2463.7335.56
Operating Expenses
414.31280.37149.4986.1145.82
Operating Income
-414.31-280.37-149.49-86.11-45.82
Interest & Investment Income
33.6323.6513.163.880.33
Other Non Operating Income (Expenses)
-55.22-17.94---0.64
EBT Excluding Unusual Items
-435.9-274.66-136.33-82.23-46.12
Gain (Loss) on Sale of Investments
11.1114.6710.110.37-0.22
Pretax Income
-424.79-259.99-126.22-81.85-46.34
Income Tax Expense
0.590.76---
Net Income
-425.38-260.76-126.22-81.85-46.34
Net Income to Common
-425.38-260.76-126.22-81.85-46.34
Shares Outstanding (Basic)
7366585022
Shares Outstanding (Diluted)
7366585022
Shares Change (YoY)
9.45%14.06%17.22%128.01%659.75%
EPS (Basic)
-5.85-3.93-2.17-1.65-2.13
EPS (Diluted)
-5.85-3.93-2.17-1.65-2.13
EBIT
-414.31-280.37-149.49-86.11-45.82
Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q